What is Applied Biosciences Corp. (APPB) stock price today?

Applied Biosciences Corp. (APPB) is currently trading at $0.00.

What is APPB return on equity (ROE)?

Applied Biosciences Corp.'s return on equity (ROE) is 93.90%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is Applied Biosciences Corp.'s market cap?

Applied Biosciences Corp. has a market capitalization of $1365.

OTC · Drug Manufacturers - Specialty & Generic

Applied Biosciences Corp. (APPB) Stock

$0.00 OTC: APPB Healthcare

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments.

Valuation

Metric	Value
Price	$0.00
Market Cap	$1365
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.02
EPS (TTM)	$-0.06
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	93.90%
ROA	-100.00%
ROCE	-117.71%
Gross Margin	-358.52%
Operating Margin	-781.32%
Net Margin	-865.30%
Debt/Equity	-0.94
Current Ratio	0.01

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$1.0M	$1.0M	$0
Operating Profit	$-1.0M	$-1.0M	$-3.0M	$-3.0M	$-1.0M
Net Profit	$-1.0M	$-2.0M	$-3.0M	$-5.0M	$-1.0M
EPS	$-0.04	$-0.16	$-0.22	$-0.34	$-0.06
Op Margin	-1132.5%	-303.5%	-374.3%	-427.1%	-781.3%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$2.0M	$1.0M	$4.0M	$3.0M	$1.0M
Total Liabilities	$0	$0	$0	$4.0M	$1.0M
Cash	$0	$0	$0	$1.0M	$0
Borrowings	$0	$0	$0	$0	$0

Latest News

Hungarian companies pivot after Orban’s allies lose political influence Investing.com · Aug 2, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$0	$-1.0M	$-1.0M	$-1.0M	$-1.0M
Investing Cash Flow	$-1.0M	$0	$-1.0M	$0	$0
Financing Cash Flow	$0	$0	$0	$2.0M	$0
Net Cash Flow	$0	$0	$0	$0	$-1.0M
Free Cash Flow	$0	$-1.0M	$-1.0M	$-1.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.38
FCF Yield	-54923.81%
Quick Ratio	0.01
Interest Coverage	—
Return 1Y	0.00%
Return 3Y	-88.89%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALIDAllied Corp.	$0.00	—	0.00	$57748	0.00%
BINPBionoid Pharma, Inc.	$0.03	+0.00%	-3.53	$1.62M	0.00%
CBDYTarget Group Inc.	$0.00	—	-0.41	$740431	0.00%
CNNACann American Corp.	$0.01	+8.33%	0.53	$4.80M	0.00%
CPMDCannaPharmaRX, Inc.	$0.00	—	-0.13	$1.42M	0.00%

About Applied Biosciences Corp.

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.

Applied Biosciences Corp. (APPB) stock trades at $0.00 with a market capitalization of $1365. The stock is valued at price-to-book of 0.00, price-to-sales of 0.02.

On profitability, Applied Biosciences Corp. generates a return on equity (ROE) of 93.90% (not meaningful, as shareholders' equity is negative), return on capital employed of -117.71%, an operating margin of -781.32%, a net profit margin of -865.30%.

Official website: www.appliedbiocorp.com